In patients with chronic stable angina,<unk>  remain the mainstay of therapy. Organic<unk>  are therapeutic precursors of endothelium-derived relaxing factor that produce their beneficial effects both, by decreasing myocardial oxygen requirements and by improving myocardial perfusion. The most commonly used<unk>  are nitroglycerin, isosorbide dinitrate and isosorbide mononitrate. Short acting<unk> , such as sublingual nitroglycerin, are best suited to treat acute episodes of angina and are effective when used for situational prophylaxis. Long-acting<unk>  help to reduce the frequency and severity of angina and may increase exercise tolerance in patients with stable angina.<unk>  at therapeutic doses do not affect coronary vascular resistance, thereby reducing the risk of myocardial ischemia due to coronary steal phenomena that is consistent with the use of dipyridamole and other short acting dihydropyridines.
Chronic stable angina treatment nitrates
Chronic stable angina treatment aspirin
Chronic stable angina treatment beta blockers
Chronic stable angina treatment potassium channel openers
Chronic stable angina treatment calcium channel blockers
Chronic stable angina treatment anti-lipid agents
Chronic stable angina treatment dipyridamole
Chronic stable angina treatment angiotensin converting enzyme inhibitors 